A patient with metastatic breast cancer has made a dramatic recovery after receiving a personalised therapy using her own cells.
A 21-gene test performed on tumours could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study.
Japanese scientists now have permission to treat people who have heart disease with cells produced by a revolutionary reprogramming technique, which excites researchers. But some fear the therapy will be rushed to market.
Although reprogrammed viruses are commonly used in gene therapy to treat diseases, this virus can do its work without affecting healthy cells.
The FDA is coming down hard on pharma following generic drug stalling tactics. This follows the recent publication from the agency of an online list of pharma companies that together have racked up 150 complaints from generics makers seeking samples.
The NIH’s All of Us Research Program issued a funding announcement yesterday for Genome Centres to generate genotype and whole genome sequence data from participants’ biosamples.
Start-up X Genomics has revealed its X Genomics Human Variant Genome Project, which aims to bring together genome specialists to build a genetic data chain powered by the blockchain.
Scientists have successfully developed a far easier way to manipulate different genes by using a common research model, baker’s yeast.
In this open discussion webinar, DNA Genotek and Illumina discuss what’s trending in whole genome sequencing (WGS).
Three years ago a team of scientists built the first synthetic yeast chromosome, and today they have got one giant step closer to their goal of creating a complex organism.